Fermenta Biotech Stock Screener | Share Price & Fundamental Analysis
FERMENTA
Pharmaceuticals
Screen Fermenta Biotech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹339.25
▼
-6.80 (-1.97%)
Market Cap
₹1,009.54 Cr.
P/E Ratio (TTM)
9.01
P/B Ratio
2.55
EPS (TTM)
₹26.35
Dividend Yield
0.73%
Debt to Equity
0.39
52W High
₹416.85
52W Low
₹225.35
Operating Margin
20.00%
Profit Margin
13.24%
Revenue (TTM)
₹136.00
EBITDA
₹32.00
Net Income
₹18.00
Total Assets
₹615.00
Total Equity
₹359.00
Fermenta Biotech Share Price History - Stock Screener Chart
Screen FERMENTA historical share price movements with interactive charts. Analyze price trends and patterns.
Fermenta Biotech Company Profile - Fundamental Screener
Screen Fermenta Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FERMENTA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE225B01021
Fermenta Biotech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen FERMENTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 615 | 548 | 637 | 707 | 687 | 614 | 551 | 387 | 308 | 288 |
| Current Assets | 335 | 242 | 253 | 314 | 310 | 284 | 296 | 182 | 104 | 95 |
| Fixed Assets | 227 | 269 | 267 | 299 | 263 | 200 | 178 | 177 | 172 | 168 |
| Liabilities | ||||||||||
| Total Liabilities | 615 | 548 | 637 | 707 | 687 | 614 | 551 | 387 | 308 | 288 |
| Current Liabilities | 44 | 89 | 115 | 128 | 117 | 110 | 145 | 146 | 49 | 24 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 359 | 285 | 313 | 372 | 360 | 309 | 251 | 137 | 173 | 156 |
| Share Capital | 15 | 14 | 14 | 14 | 14 | 14 | 5 | 2 | 2 | 2 |
| Reserves & Surplus | 348 | 274 | 301 | 358 | 346 | 295 | 246 | 124 | 142 | 128 |
Screen FERMENTA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 136 | 145 | 144 | 159 | 98 | 81 | 103 | 102 | 59 | 85 | 106 | 55 | 101 | 96 | 99 |
| Expenses | 104 | 108 | 103 | 103 | 76 | 77 | 92 | 74 | 78 | 72 | 95 | 84 | 95 | 87 | 78 |
| EBITDA | 32 | 37 | 41 | 56 | 22 | 4 | 11 | 28 | -19 | 13 | 11 | -29 | 6 | 9 | 21 |
| Operating Profit % | 20.00% | 21.00% | 26.00% | 34.00% | 20.00% | 1.00% | 6.00% | 25.00% | -38.00% | 13.00% | 10.00% | -53.00% | 3.00% | 5.00% | 18.00% |
| Depreciation | 5 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 6 | 9 | 7 | 7 |
| Interest | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 5 | 4 | 5 | 6 | 5 | 5 | 5 | 4 |
| Profit Before Tax | 24 | 28 | 32 | 45 | 12 | -6 | 1 | 16 | -29 | 2 | -1 | -41 | -8 | -2 | 10 |
| Tax | 6 | 7 | -1 | 8 | 1 | 0 | 8 | 6 | 0 | 0 | 4 | -3 | 1 | 0 | 2 |
| Net Profit | 18 | 22 | 33 | 38 | 11 | -6 | -7 | 10 | -29 | 2 | -5 | -38 | -9 | -3 | 8 |
| EPS | 6.48 | 7.49 | 11.79 | 12.71 | 3.94 | -2.01 | -2.41 | 3.41 | -7.32 | 0.64 | -1.42 | -12.97 | -2.80 | -0.90 | 2.66 |
Fermenta Biotech Cash Flow Screener - Liquidity Fundamentals
Screen FERMENTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 41 | 105 | 116 | 43 | 63 | 35 | 90 | 59 | 2 | 4 |
| Investing Activities | 0 | -16 | -55 | -26 | -41 | -44 | -97 | -101 | 7 | -13 |
| Financing Activities | -51 | -91 | -41 | -22 | -1 | -48 | 12 | 89 | -12 | 10 |
| Net Cash Flow | -10 | -1 | 19 | -4 | 21 | -57 | 6 | 47 | -4 | 2 |
Screen FERMENTA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 64.09% | 64.09% | 64.09% | 62.06% | 62.06% | 62.06% | 62.06% | 59.58% |
| FII Holding | 0.02% | 0.02% | 0.02% | 0.00% | 0.00% | 0.05% | 0.02% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.38% | 29.60% | 29.76% | 32.47% | 32.51% | 31.29% | 32.31% | 33.99% |
| Other Holding | 5.51% | 6.29% | 6.12% | 5.47% | 5.43% | 6.59% | 5.60% | 6.42% |
| Shareholder Count | 12,930 | 12,845 | 13,760 | 15,178 | 14,589 | 13,221 | 12,922 | 16,897 |
Fermenta Biotech Dividend Screener - Share Yield Analysis
Screen FERMENTA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.50 | 0.74% |
| 2024-March | ₹1.25 | 0.46% |
| 2023-March | ₹1.25 | 0.83% |
| 2022-March | ₹1.25 | 1.12% |
| 2021-March | ₹2.50 | 1.22% |
| 2020-March | ₹5.00 | 2.00% |
| 2019-March | ₹1.25 | 0.59% |
| 2018-March | ₹2.50 | 0.91% |
| 2017-March | ₹2.50 | 1.05% |
Fermenta Biotech Index Membership - Market Screener Classification
Screen FERMENTA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Fermenta Biotech Market Events Screener - Corporate Actions
Screen FERMENTA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.25 /share | 19.56% | ||
| Extraordinary General Meeting | NA | -5.20% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 3.74% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -2.81% |
| 2025-08-12 | 2025-08-12 | Annual General Meeting | NA | 17.70% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 2.50 /share | 22.43% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.97% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 11.80% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.12% |
| 2024-08-12 | 2024-08-12 | Annual General Meeting | NA | 52.13% |
| 2024-08-06 | 2024-08-06 | Dividend | ₹ 1.25 /share | 46.02% |
| 2022-08-04 | 2022-08-05 | Dividend | ₹ 1.25 /share | -3.77% |
| 2021-08-25 | 2021-08-27 | Dividend | ₹ 2.50 /share | -12.85% |
| 2020-02-13 | 2020-02-14 | Bonus | 2:1 | 15.38% |
| 2019-11-05 | 2019-11-05 | Change Of Name | NA | 0.00% |
Fermenta Biotech Competitors Screener - Peer Comparison
Screen FERMENTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,705 | 40.28 | 54,729 | 9.71% | 10,980 | 58.99 |
| Divis Laboratories | 176,338 | 70.98 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 138,499 | 62.26 | 11,539 | 6.99% | 1,911 | 80.95 |
| Cipla | 118,573 | 22.75 | 28,410 | 7.12% | 5,291 | 38.52 |
| Dr Reddys Laboratories | 103,728 | 18.27 | 33,741 | 16.73% | 5,725 | 40.17 |
| Lupin | 101,149 | 22.61 | 22,910 | 13.74% | 3,306 | 71.67 |
| Mankind Pharma | 95,432 | 52.17 | 12,744 | 20.90% | 2,007 | 64.16 |
| Zydus Life Science | 93,333 | 18.63 | 23,511 | 18.55% | 4,615 | 52.14 |
| Aurobindo Pharma | 71,752 | 20.91 | 32,346 | 9.43% | 3,484 | 61.25 |
| Alkem Laboratories | 69,425 | 28.04 | 13,458 | 3.70% | 2,216 | 63.97 |
Fermenta Biotech Company Announcements - News Screener
Screen FERMENTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-24 | Press Release | View |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2025-12-10 | Board Meeting Outcome for Approval For The Proposal For Raising Of Funds. | View |
| 2025-12-10 | Update On Capacity Addition At Dahej Facility. | View |
| 2025-12-07 | Board Meeting Intimation for To Consider The Proposal For Raising Of Funds. | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Press Release With Respect To Financial Results Of H1FY26 | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-11 | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-29 | Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-24 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-24 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-10-02 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-09-30 | Newspaper Publication Regarding Saksham Niveshak Campaign By IEPF | View |
| 2025-09-29 | Closure of Trading Window | View |